Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 2/20 | 0.69 |
| ▸ | MGLL | Q99685 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | CNR1 | P21554 | 1/20 | 0.65 |
| ▸ | FAAH | O00519 | 3/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | PRKCA | P17252 | 1/20 | 0.60 |
| ▸ | TERT | O14746 | 3/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | BLM | P54132 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12804058 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL10656684 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL8609157 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL12804338 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL8982888 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL12803661 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL8982680 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL10656683 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL12804063 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB | |
| SCHEMBL8609155 | 1.00 | DGKA (0.69) | DGKAMGLLMAPTALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354765-A1 | SYSTEMS AND METHODS FOR MANAGING THERMAL ENERGY | PHASESTOR LLC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-3948138-B1 | THERMAL MANAGEMENT DEVICES AND METHODS | PHASE CHANGE ENERGY SOLUTIONS INC (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-4042086-B1 | SYSTEMS AND METHODS FOR MANAGING THERMAL ENERGY | PHASESTOR LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-12372289-B2 | Temperature control cart for a payload | VESTURE LLC (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250207845-A1 | PRODUCT TRANSPORT CONTAINERS | VESTURE LLC (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250207841-A1 | TEMPERATURE CONTROL CART FOR A PAYLOAD | VESTURE LLC (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250207867-A1 | THERMAL ENERGY STORAGE SYSTEMS | PHASESTOR LLC (US) | 2025-06-26 | — | — | US | disclosed |
| US-12320583-B2 | Systems for storing and/or transporting temperature-sensitive payloads | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250172320-A1 | CHARGING SYSTEM AND CHARGING CRADLE FOR FOOD TRANSPORTATION SYSTEMS | VESTURE LLC (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250129995-A1 | HYBRID SYSTEMS AND METHODS FOR MANAGING THERMAL ENERGY | PHASESTOR LLC (US) | 2025-04-24 | — | — | US | disclosed |
| US-20150082691-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | ARES CAPITAL CORPORATION | 2015-03-26 | — | — | US | disclosed |
| US-8906665-B2 | Methods and compositions for the recombinant biosynthesis of fatty acids and esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| WO-2014031605-A1 | THERMAL ENERGY STORAGE SYSTEMS | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20130143306-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2013-06-06 | — | — | US | disclosed |
| US-8399227-B2 | Methods and compositions for the recombinant biosynthesis of fatty acids and esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2013-03-19 | — | — | US | disclosed |
| US-8366819-B2 | Oily inkjet ink | RISO KAGAKU CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20120009636-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| US-8048654-B2 | Methods and compositions for the recombinant biosynthesis of fatty acids and esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-20110232528-A1 | OILY INKJET INK | RISO KAGAKU CORPORATION (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110111470-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | JOULE UNLIMITED, INC. (US) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110111470-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | FASN, FADS2, FADS1 | DGKA 215/4885MGLL 72/4885MAPT 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.